We found that patients with high expression levels of both CCN3 and OPN have the poorest prognosis, and CCN3 may be advantageous for the management of HCC metastasis because CCN3 correlates with OPN regulation and activation of the ERK and NFκB signaling pathways. The gene discussed is SPP1; the disease is hepatocellular carcinoma.